Table of adherence to 2016 ACMG guidance for NIPS laboratories
Information about prenatal screening and testing options:
Non-invasive prenatal testing (NIPT):
- Mayo Clinic
- Genetic Support Foundation
- National Coalition for Health Professional Education in Genetics (NHCPEG)
Genetic conditions detected by NIPT:
- Chromosome aneuploidies:
- Down syndrome (trisomy 21)
- Trisomy 18 (Edward syndrome)
- Trisomy 13 (Patau syndrome)
- Turner syndrome (45,X)
- Klinefelter syndrome (47,XXY)
- Jacob syndrome (47,XYY)
- Trisomy X (47,XXX or Triple X syndrome)
- 48,XXYY
- Trisomy 16
- Trisomy 22
- Triploidy
- Unique (Rare Chromosome Disorder Support Group)
- Microdeletions:
- 22q11.2 deletion syndrome (DiGeorge syndrome, Velocardiofacial syndrome [VCFS])
- 5p deletion syndrome (Cri-du-chat)
- Prader-Willi syndrome
- Angelman syndrome
- 1p36 deletion syndrome
- 11q deletion syndrome (Jacobsen syndrome)
- Langer-Giedion syndrome (8q deletion, trichorhinophalagneal syndrome II [TRSP2])
- 4p deletion syndrome (Wolf-Hirshhorn syndrome)
Research trials examining the efficacy of NIPT:
- United Kingdom’s RAPID project (Reliable Accurate Prenatal non-Invasive Diagnosis)
- Canada’s PEGASUS project (PErsonalized Genomics for prenatal Aneuploidy Screening USing maternal blood)
NIPT testing labs and companies:
- Based in the United States; some also offer their test to customers outside the United States:
- Ariosa’s Harmony™
- LabCorp’s informaSeq℠
- Natera’s Panorama™
- Sequenom’s MaterniT21 PLUS™ (information available for patients, for providers, or for insurance)
- Verinata’s verifi®
- Based outside the United States:
- Berry Genomics’s BambniTest™
- BGI’s NIFTY™
- GENDIA
- Igenomix NACE
- LifeCodexx’s PrenaTest®
To suggest additional resources to include on this page, please Contact Us.